Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to assess the safety and initial effectiveness of the TIVUS™ System when used for pulmonary artery denervation in group II PH patients through change in clinical parameters including hemodynamics, exercise tolerance, and quality of life. This is a prospective, multi-center, non-randomized, open-label clinical trail. The study will be conducted in up to 3 centers and will recruit up to 15 patients diagnosed with pulmonary hypertension due to left heart disease that demonstrate combined pre and post capillary involvement with PVR>3 wood units.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03611270
Study type Interventional
Source SoniVie Inc.
Contact
Status Active, not recruiting
Phase N/A
Start date November 30, 2018
Completion date July 2027